Human T-lymphoblastic lymphoma/leukemia cells have shown to overexpress Bcl-2, accelerating malignant transformation by suppressing Myc-induced apoptosis [36]. The gene discussed is BCL2; the disease is T-lymphoblastic lymphoma.